DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC

NCT04967482 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma Non-resectable

Interventions

PROCEDURE: Drug-eluting bead transarterial chemoembolization (DEB-TACE)
PROCEDURE: Conventional transarterial chemoembolization (cTACE)

Sponsor

Second Affiliated Hospital of Guangzhou Medical University